Literature DB >> 27730433

Inflammation and Fibrosis in ADPKD.

Hyowon Mun1, Jong Hoon Park2.   

Abstract

Diverse signaling pathways have been reported to be associated with polycystic kidney disease (PKD). Cell proliferation is widely known to be an important pathway related to this disease. However, studies on the interactions of inflammation and fibrosis with polycystic kidney disease have been limited. Inflammation is one of the protective systems involved in the response to foreign molecules. In PKD, it was reported that the activity of signaling pathways associated with inflammation is increased. Also, fibrosis is the development of excess fibrous tissue in organ or tissue. It is an abnormal phenomenon in which the extent of fibrous connective tissues is increased. In PKD, increases in the activity of molecules such as growth factor and TGF-β have been reported to occur and promote fibrosis. Therefore, the inflammation and fibrosis responses have been suggested as therapeutic targets for PKD. In order to guide further studies, this review indicates the roles of inflammatory and fibrosis signaling in PKD.

Entities:  

Keywords:  Fibrosis; Inflammation; Macrophage; Polycystic kidney disease; TGF-beta; TNF-alpha

Mesh:

Year:  2016        PMID: 27730433     DOI: 10.1007/978-981-10-2041-4_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

2.  Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Brian E Jones; Yaman G Mkhaimer; Laureano J Rangel; Maroun Chedid; Phillip J Schulte; Alaa K Mohamed; Reem M Neal; Dalia Zubidat; Amarjyot K Randhawa; Christian Hanna; Adriana V Gregory; Timothy L Kline; Ziad M Zoghby; Sarah R Senum; Peter C Harris; Vicente E Torres; Fouad T Chebib
Journal:  Kidney360       Date:  2021-12-07

3.  Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.

Authors:  Yuta Kasagi; Kara Dods; Joshua X Wang; Prasanna M Chandramouleeswaran; Alain J Benitez; Fiona Gambanga; Jonathan Kluger; Tokunbo Ashorobi; Jonathan Gross; John W Tobias; Andres J Klein-Szanto; Jonathan M Spergel; Antonella Cianferoni; Gary W Falk; Kelly A Whelan; Hiroshi Nakagawa; Amanda B Muir
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 14.290

Review 4.  Unique interstitial miRNA signature drives fibrosis in a murine model of autosomal dominant polycystic kidney disease.

Authors:  Ameya Patil; William E Sweeney; Cynthia G Pan; Ellis D Avner
Journal:  World J Nephrol       Date:  2018-09-07

5.  Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.

Authors:  Matanel Yheskel; Ronak Lakhia; Patricia Cobo-Stark; Andrea Flaten; Vishal Patel
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.